Digestion
Original Paper
Colonoscopic Findings and Pathologic Characteristics of Strongyloides Colitis: A Case SeriesMinematsu H.a · Hokama A.c · Makishi T.a · Arakaki K.b · Kinjo F.d · Fujita J.caGastroenterology Unit and bPathology Unit, Tomishiro Central Hospital, Tomigusuku, and cDepartment of Infectious, Respiratory and Digestive Medicine, University of the Ryukyus, and dEndoscopy Unit, University Hospital of the Ryukyus, Nishihara, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 21, 2011
Issue release date: January 2011
Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 2
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Abstract
Background/Aims: Strongyloidiasis, which is caused by Strongyloides stercoralis, is one of the prevalent infections in the tropical and subtropical regions worldwide. The larvae mainly infect the small intestine and cause serious disseminated strongyloidiasis. Although upper gastrointestinal features in strongyloidiasis are well known, colonoscopic evaluation has not been established yet. The aim of this study is to clarify the characteristic findings on colonic lesions in strongyloidiasis. Method: From January 2005 to December 2009, 10 cases with strongyloidiasis underwent colonoscopy at a single center on an endemic island of Japan. The clinical and colonoscopic findings were analyzed retrospectively. Results: Six (60%) cases had an immunocompromised condition, including human T lymphotropic virus type 1 infection, corticosteroids, and chemotherapy. Hyperinfection or disseminated strongyloidiasis was not presented. Endoscopic features included yellowish-white nodules, erythema, and loss of vascular pattern, which were mainly observed in the right colon. Pathological examination revealed the filariform Strongyloides larvae and the eosinophilic infiltration of the lamina propria. Conclusion: This study demonstrates that colonoscopic observation and biopsies are very useful to diagnose strongyloidiasis. Asymptomatic cases with strongyloidiasis can have colonic involvement. Yellowish-white nodules may be a characteristic finding of colonic lesions in strongyloidiasis and can be a cautious marker to prevent fatal disseminated strongyloidiasis in endemic regions.
© 2011 S. Karger AG, Basel
Related Articles:
References
- Concha R, Harrington W Jr, Rogers AI: Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203–211.
- Arakaki T, Iwanaga M, Kinjo F, et al: Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 1990;76:425–428.
- Grove DI: Strongyloidiasis: a conundrum for gastroenterologists. Gut 1994;35:437–440.
- Kishimoto K, Hokama A, Hirata T, et al: Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J Gastroenterol 2008;14:1768–1773.
- Thompson BF, Fry LC, Wells CD, et al: The spectrum of gastrointestinal strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc 2004;59:906–910.
- Sridhara S, Simon N, Raghuraman U, et al: Strongyloides stercoralis pancolitis in an immunocompetent patient. Gastrointest Endosc 2008;68:196–199.
-
Bras G, Richards RC, Irvine RA, et al: Infection with Strongyloides stercoralis in Jamaica. Lancet 1964;ii:1257–1260.
External Resources
- Stemmermann GN: Strongyloidiasis in migrants. Pathological and clinical considerations. Gastroenterology 1967;53:59–70.
- Civantos F, Robinson MJ: Fatal strongyloidiasis following corticosteroid therapy. Am J Dig Dis 1969;14:643–651.
- De Goede E, Martens M, Van Rooy S, et al: A case of systemic strongyloidiasis in an ex-coal miner with idiopathic colitis. Eur J Gastroenterol Hepatol 1995;7:807–809.
- Powell RW, Moss JP, Nagar D, et al: Strongyloidiasis in immunosuppressed hosts. Presentation as massive lower gastrointestinal bleeding. Arch Intern Med 1980;140:1061–1063.
- Carp NZ, Nejman JH, Kelly JJ: Strongyloidiasis. An unusual cause of colonic pseudopolyposis and gastrointestinal bleeding. Surg Endosc 1987;1:175–177.
- Kang JY, Yap I: Colitis due to strongyloidiasis. Gastrointest Endosc 1989;35:71–72.
- Murphy RA, Barton G, Pinkas H: Severe colitis due to Strongyloides stercoralis in a patient with cutaneous Kaposi’s sarcoma. Gastrointest Endosc 1991;37:79–82.
- Stoopack PM, Raufman JP: Aphthoid ulceration of the colon in strongyloidiasis. Am J Gastroenterol 1991;86:639–642.
- Choudhry U, Choudhry R, Romeo DP, et al: Strongyloidiasis: new endoscopic findings. Gastrointest Endosc 1995;42:170–173.
- Al Samman M, Haque S, Long JD: Strongyloidiasis colitis: a case report and review of the literature. J Clin Gastroenterol 1999;28:77–80.
- Sato Y, Kobayashi J, Toma H, et al: Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995;53:248–250.
- Rosenblatt JE: Clinical importance of adequately performed stool ova and parasite examinations. Clin Infect Dis 2006;42:979–980.
- Zaha O, Hirata T, Kinjo F, et al: Efficacy of ivermectin for chronic strongyloidiasis: two single doses given two weeks apart. J Infect Chemother 2002;8:94–98.
Article / Publication Details
Published online: January 21, 2011
Issue release date: January 2011
Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 2
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
